This is the
talk page for discussing improvements to the
Chang Yi Wang article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google ( books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
![]() | This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to multiple WikiProjects. | ||||||||||||||||||||||||
|
![]() | The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE. |
Hello fellow Wikipedians,
I have just modified 2 external links on Chang Yi Wang. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
When you have finished reviewing my changes, please set the checked parameter below to true or failed to let others know (documentation at {{
Sourcecheck}}
).
This message was posted before February 2018.
After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than
regular verification using the archive tool instructions below. Editors
have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the
RfC before doing mass systematic removals. This message is updated dynamically through the template {{
source check}}
(last update: 5 June 2024).
Cheers.— InternetArchiveBot ( Report bug) 11:04, 19 November 2016 (UTC)
Hello fellow Wikipedians,
I have just modified 4 external links on Chang Yi Wang. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
{{
dead link}}
tag to
http://www.unitedbiomedical.com/Press/Detail.asp?SN=42%2FWhen you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
This message was posted before February 2018.
After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than
regular verification using the archive tool instructions below. Editors
have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the
RfC before doing mass systematic removals. This message is updated dynamically through the template {{
source check}}
(last update: 5 June 2024).
Cheers.— InternetArchiveBot ( Report bug) 19:34, 2 August 2017 (UTC)
The following Wikimedia Commons files used on this page have been nominated for deletion:
Participate in the deletion discussion at the nomination page. — Community Tech bot ( talk) 12:06, 18 April 2019 (UTC)
![]() | This edit request by an editor with a conflict of interest has now been answered. |
Dr. Wang is the author of more than 120 peer-reviewed scientific publications and she is the inventor of more than 80 patents to date [1].
In 2007, the New York Intellectual Property Law Association (NYIPLA) presented Wang with the Inventor of the Year Award [2] [3] [4].
In 2018, the Brain Mapping Foundation presented Dr. Wang with the Pioneer in Technology Award [5] [6].
Dr. Wang graduated with honor from National Taiwan University in 1973, majoring in chemistry. She received a Ph.D. degree from Rockefeller University with dual specialization in Biochemistry and Immunology in 1979 and then joined the Memorial Sloan Kettering Cancer Center as the youngest faculty member, principal investigator and head of the molecular immunology laboratory [7].
References
{{
cite patent}}
template.{{
request edit}}
template's answer parameter to read from |ans=yes
to |ans=no
. Thank you!Regards, Spintendo 11:49, 12 October 2019 (UTC)
Notes
References
...articles should not give minority views or aspects as much of or as detailed a description as more widely held views or widely supported aspects.
1. I modified my request adding content to only those easily been confirmed sourced.
2. BioTaiwan interview indicate her education background and her role in Memorial Sloan Kettering Cancer Center, but I can't get information from the employer. Can waive Early life and education content for now if you still advise lacking sufficient resource.
3. About patent, I don't list the details here, so just referring to United Biomedical website publication information page.
4. Biotaiwan Foundation's official name is "Biotechnology Industry Study Centre", an important organization of Taiwanese biologics industry.
Cmhu ( talk) 16:07, 12 October 2019 (UTC)
1. These two awards have no independent wiki, but the organization did have wiki and mention these two awards.
Are they reliable enough for citation? Please advise.
2. NYIPLA is someone else's edition, I'm just adding extra information resource. I'm ok if no further modification on that.
3. I would like to remove BioTaiwan's reference since it made the citation more complicated.
4. Do you think I'm ok to post or I need to modify request edit|ans=yes to ans=no every reply and then wait for you to post for me?
Thank you!
Cmhu (
talk)
00:49, 13 October 2019 (UTC)
Cmhu
![]() | This edit request by an editor with a conflict of interest has now been answered. |
Dr. Wang founded United Biomedical, Inc. (UBI), headquartered in Hauppauge, New York in 1985 [1], and its group of companies in Asia : UBI Asia in 1998 [2], United Biopharma in 2013 [3], and UBI Pharma in 2014 [4] respectively. Dr. Wang advocated “immunology as a secret weapon in medicine,” devoted decades of years in synthetic peptides technology [5]. In 2009, Bill and Melinda Gates Foundation Awarded Grand Challenges Exploration Grants to Dr. Wang, for the Synthetic Peptides to Inhibit HIV Entry program [6].
The first involved developing a synthetic peptide-based HIV 1, and later an HIV 1,2 diagnostic test for blood screening, both of which received U.S. Food and Drug Administration approval, in 1989 and 1996, respectively [7] [8]. These tests were subsequently recognized by the World Health Organization (WHO) as being suitable for worldwide use [9].
Her other contributions in this area include synthetic peptide-based blood screening diagnostics for HTLV I/II [10] and the Hepatitis C virus (HCV) (publication 53), which received CE mark certification and was sold in the global market through Organon Teknika /Biomerieux since 1991 [11].
— Preceding unsigned comment added by Cmhu ( talk • contribs) 08:20, 15 October 2019 (UTC)
References
Some issues with the requested text:
{{
request edit}}
template's answer parameter to read from |ans=yes
to |ans=no
. Also, (Please remember to
sign your posts on talk pages by typing four keyboard
tildes like this: ~~~~
. Or, you can use the
[ reply ] button, which automatically signs posts.) Thank you!Regards, Spintendo 13:31, 15 October 2019 (UTC)
Notes
![]() | This edit request by an editor with a conflict of interest was declined. Please see the reply below for additional information about this request. |
Dr. Wang founded United Biomedical, Inc. (UBI), headquartered in Hauppauge, New York in 1985 [1], and its group of companies in Asia : UBI Asia in 1998 [2], United Biopharma in 2013 [3], and UBI Pharma in 2014 [4] respectively.
Chang Yi Wang devoted decades of years in synthetic peptides technology [5]. In 2009, Bill and Melinda Gates Foundation Awarded Grand Challenges Exploration Grants to Dr. Wang, for the Synthetic Peptides to Inhibit HIV Entry program [6].
References
1. Removed some complicated sentences for now.
2.
https://gcgh.grandchallenges.org/grant/synthetic-peptides-inhibit-hiv-entry : Chang Yi Wang of ..., the source of Bill and Melinda Gates Foundation sentence.
...devoted decades of years...); and (d) not referenced by reliable independent WP:SECONDARY sources (i.e., her research into synthetic peptides). Additionally, (e) the claim regarding the 'Grand Challenges' grant was not added, because information found in the Bill & Melinda Gates Foundation article only references that grant as being complimentary to the Foundation's Reinvent the Toilet campaign. For these reasons the edit request is declined. Regards, Spintendo 09:29, 7 November 2019 (UTC)
Chang Yi Wang also founded UBI Asia subsidiary companies in Asia : United Biopharma in 2013 [1] and UBI Pharma in 2014 [2] respectively.
In 2009, Bill and Melinda Gates Foundation Awarded Grand Challenges Exploration Grants to Chang Yi Wang, for the Synthetic Peptides to Inhibit HIV Entry program [3].
References
1. Removed duplicate information.
2. Modified content.
3. "Chang Yi Wang of United Biomedical, Inc. in the United States will develop and test synthetic peptide immunogens that mimic conserved sites used by HIV to gain entry to host T-cells. Mimicking the correct three-dimensional structure of these important proteins should generate antibody responses that block this initial step of HIV infection and neutralize the virus." From Bill and Melinda Gates Foundation official website Awarded Grants webpage, isn't it a clear and reliable resource?
Cmhu (
talk)
10:37, 7 November 2019 (UTC)